Q3 2022 Erytech Pharma SA Earnings Call Transcript
Good morning, and thank you for standing by. Welcome to the ERYTECH business update and financial highlights for the third quarter of year 2022. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to turn the conference over to your speaker today, Gil Beyen, CEO of ERYTECH. Please go ahead.
Thank you. Good afternoon. Good morning. Bonjour Ă tous. Thank you for joining us for our business and financial update call to discuss the business highlights for the third quarter of 2022 and the financials for the first nine months of this year.
We announced our business and financial update yesterday evening, and the press release and webcast presentation can be found on the Investor Relations page of our website.
Turning to slide 2, before starting, as usual, I have to draw your attention to disclaimer to remind you that today's call includes forward-looking statements. And as you know, they all involve risks and uncertainties that could cause actual
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investorsâ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |